A recent study identifies significant diagnostic testing gaps for antiphospholipid syndrome within a healthcare system. This research highlights the need for improved testing protocols to enhance diagnosis and treatment.

A recent study published in PubMed explores the epidemiology and outcomes of antiphospholipid syndrome in the context of evolving diagnostic criteria. The findings contribute to a better understanding of this rare disease and its impact on patient outcomes.

Recent research highlights the dysfunction of the protein C pathway in antiphospholipid syndrome, suggesting potential new therapeutic avenues. This study may pave the way for innovative treatments targeting this pathway.

A NIH-funded clinical trial demonstrates that a symptom-based approach effectively treats opioid withdrawal in newborns with minimal drug exposure, potentially reducing hospital stay durations. This innovative strategy could reshape care protocols for affected infants.

A 47-year-old woman in Germany was cured of three severe autoimmune diseases—autoimmune hemolytic anemia, immune thrombocytopenia, and antiphospholipid syndrome—using CAR-T cell therapy, traditionally used for blood cancers. This breakthrough highlights the potential of CAR-T therapy beyond oncology, offering new hope for patients with refractory autoimmune conditions.